I CFD sono strumenti complessi e comportano un rischio significativo di perdere denaro rapidamente a causa della leva finanziaria. 70% di conti di investitori al dettaglio perdono denaro nelle negoziazioni in CFD con questo fornitore. Valuta se comprendi il funzionamento dei CFD e se puoi permetterti di correre l'elevato rischio di perdere il tuo denaro. Informativa sui rischi.
Genus PLC (GNS) is a is a world-leading animal genetics business. Headquartered in Basingstoke, UK, it sells products produced using biotechnology to pig and cattle farmers. The business has manufacturing facilities in key locations around the world, paired with sales forces in 75 countries. The Genus share price is listed on the London Stock Exchange and included in the FTSE 250 Index.
The company’s beginnings date back to 1933 when the Milk Marketing Board’s Breeding and Production Division was founded in the UK. The key breakthrough in the Genus development happened in 1999 when the business acquired ABS Global, a US-based company founded by J.R. Prentice. As of 2018, the company’s annual revenue was £470.3 million.
Check the GNS share price at Capital.com.
Sono riportate le nostre recensioni a 4 e 5 stelle. I dati individuali dell'utente sono stati intenzionalmente resi anonimi al fine di salvaguardare la sua privacy, in ottemperanza alle prescrizioni del GDPR.